๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

High-dose chemotherapy and autologous hematopoieticstem cell transplantation in patients with second primary malignancies

โœ Scribed by S. Fetscher; J. Finke; R. Engelhardt; R. Mertelsmann; W. Lange

Publisher
Springer
Year
1997
Tongue
English
Weight
134 KB
Volume
39
Category
Article
ISSN
1269-3286

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Safety and efficacy of high-dose chemoth
Safety and efficacy of high-dose chemotherapy with autologous stem cell transplantation for patients with malignant astrocytomas
โœ Benjamin Chen; Tauseef Ahmed; Anney Mannancheril; Michael Gruber; Deborah L. Ben ๐Ÿ“‚ Article ๐Ÿ“… 2004 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 92 KB ๐Ÿ‘ 1 views

## Abstract ## BACKGROUND Malignant astrocytomas are among the most resistant tumors to curative treatments. Mean survival without treatment is measured in weeks, and even with maximal surgery and radiation, the mean reported survival is < 1 year. The advent of supportive treatments and newer agen

Chemotherapy with rituximab followed by
Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma
โœ Catherine Thieblemont; Daciana Antal; Laurence Lacotte-Thierry; Vincent Delwail; ๐Ÿ“‚ Article ๐Ÿ“… 2005 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 122 KB

## Abstract ## BACKGROUND The authors evaluated the efficacy of chemotherapy combined with rituximab followed by highโ€dose therapy (HDT) plus autologous stem cell transplantation in patients with mantle cell lymphoma (MCL). ## METHODS This was a retrospective analysis of 34 patients who were tre